MAY 20, 2020 11:45 AM EDT | APAC MAY 21, 2020 2:45 PM CST

Lung Cancer Gene Fusion Assays using NanoString® nCounter® Technology

Speaker

Abstract

Personalized medicine has beomce a paradigm in lung cancer management; ~ 25–30% of advanced lung cancer patients could benefit from a targeted therapy. Several guidelines currently endorse routine genomic testing of several druggable oncogenic biomarkers—EGFR, ALK, ROS1, and BRAF—in new metastatic non-squamous NSCLC patients, while a number of other emerging molecular targets, such as RET and NTRK gene rearrangements, MET exon 14 skipping mutations (METex14), and activating HER2 or KRAS mutations are likely approaching clinical practice. Consequently, more extensive analysis such as multiplexed DNA/RNA profiling platforms are increasingly required for comprehensive biomarker testing of lung cancer. We validated the sensitivity of the NanoString® nCounter® technology to identify driver mutations (METex14) and gene fusions (ALK, ROS1, RET1, NTRK) in lung cancer patients. Our work demonstrates that embedding two DNA and RNA (using the nCounter) multiplexing technologies early into the routine workup of patients with advanced NSCLC is feasible and useful to identify distinct subsets of patients amenable to targeted therapies, resulting in significantly improved outcomes.

Research Use Only. Not for use in Diagnostic Procedures.


Show Resources
You May Also Like
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
NOV 09, 2021 11:00 AM PST
C.E. CREDITS
NOV 09, 2021 11:00 AM PST
Date: November 09, 2021 Time: 11:00am (PDT), 02:00pm (EDT) Clinical translation of human pluripotent stem cells (hPSCs) requires advanced strategies that ensure safe and robust long-term gro...
JUN 03, 2021 12:00 PM CST
JUN 03, 2021 12:00 PM CST
DATE: June 3, 2021 TIME: 12:00pm SGT This webinar is a virtual event that focuses on utilizing the Gibco CTS Rotea System for Cell and Gene Therapy...
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
Loading Comments...
Show Resources